Drug Shortage Report for CEREBYX
Report ID | 176939 |
Drug Identification Number | 02230988 |
Brand name | CEREBYX |
Common or Proper name | Cerebyx |
Company Name | SEARCHLIGHT PHARMA INC |
Market Status | MARKETED |
Active Ingredient(s) | FOSPHENYTOIN SODIUM |
Strength(s) | 75MG |
Dosage form(s) | SOLUTION LIQUID |
Route of administration | INTRAVENOUS INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR |
Packaging size | 5x2ml |
ATC code | N03AB |
ATC description | ANTIEPILEPTICS |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | 2022-12-01 |
Actual start date | 2022-12-01 |
Estimated end date | 2023-03-31 |
Actual end date | 2023-03-31 |
Shortage status | Resolved |
Updated date | 2023-04-01 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1600 RUE NOTRE DAME OUEST, SUITE 312 MONTREAL, QUEBEC CANADA H3J 1M1 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2022-12-02 | English | Compare |
v2 | 2022-12-02 | French | Compare |
v3 | 2023-01-13 | English | Compare |
v4 | 2023-01-13 | French | Compare |
v5 | 2023-02-17 | English | Compare |
v6 | 2023-02-17 | French | Compare |
v7 | 2023-03-06 | English | Compare |
v8 | 2023-03-06 | French | Compare |
v9 | 2023-03-20 | English | Compare |
v10 | 2023-03-20 | French | Compare |
v11 | 2023-04-01 | English | Compare |
v12 | 2023-04-01 | French | Compare |
Showing 1 to 12 of 12